|
2026 Journal Article Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trialLong, Millie, Allegretti, Jessica R, Danese, Silvio, Germinaro, Matthew, Baker, Thomas, Alvarez, Yelina, Kavalam, Mary, Han, Chenglong, Jörgens, Silke, Jiang, Lingjing, Zhang, Hongyan, Hisamatsu, Tadakazu, Rubin, David T, Peyrin-Biroulet, Laurent, Abu-Farsakh, Niazy, Al-Rousan, Lawrence, An, Ping, Argollo, Marjorie, Arguelles Arias, Federico, Augustyn, Monika, Baert, Filip, Balderramo, Domingo, Banerjee, Rupa, Baum, Curtis, Bermudez Villegas, Emilio, Blanco, Antonio, Bortlik, Martin, Bouhnik, Yoram, Soledad Brunatto, Luciana ... Zou, Duowu (2026). Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial. The Lancet Gastroenterology and Hepatology, 11 (4), 284-298. doi: 10.1016/S2468-1253(25)00322-X |
|
2026 Journal Article Gastrointestinal Symptoms and Systemic Comorbidities in Patients With <scp>POTS</scp> : A Systematic Review and Meta‐AnalysisKulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Gastrointestinal Symptoms and Systemic Comorbidities in Patients With POTS : A Systematic Review and Meta‐Analysis. Neurogastroenterology & Motility, 38 (4) e70305. doi: 10.1111/nmo.70305 |
|
2026 Journal Article Ready for Prime Time? Breath Testing to Diagnose Intestinal Dysbiosis and Guide Management in Patients With Functional Defecation DisordersShah, Ayesha and Holtmann, Gerald (2026). Ready for Prime Time? Breath Testing to Diagnose Intestinal Dysbiosis and Guide Management in Patients With Functional Defecation Disorders. Neurogastroenterology and Motility, 38 (4) e70275. doi: 10.1111/nmo.70275 |
|
2026 Journal Article symptom patterns outside the rome iv consensus in eastern and western patients with a disorder of gut-brain interactionColomier, Esther, Jones, Michael P., Holvoet, Lieselot, Van den Houte, Karen, Van de Bruaene, Cedric, Broeders, Bert, Bai, Tao, Liu, Jinsong, Melchior, Chloé, Gourcerol, Guillaume, Chuah, Kee-Huat, Hui, Khoo Xin, Mahadeva, Sanjiv, Ho Siah, Kewin Tien, Lipták, Peter, Banovcin, Peter, Holtmann, Gerald, Koloski, Natasha, Carabotti, Marilia, Annibale, Bruno, Suzuki, Hidekazu, Sano, Masaya, Ueda, Takashi, Hajihashemi, Parisa, Shahoon, Hassan, Adibi, Payman, Simrén, Magnus, Gwee, Kok-Ann, Tack, Jan and Carbone, Florencia (2026). symptom patterns outside the rome iv consensus in eastern and western patients with a disorder of gut-brain interaction. American Journal of Gastroenterology, Publish Ahead of Print 10.14309/ajg.0000000000003996. doi: 10.14309/ajg.0000000000003996 |
|
2026 Conference Publication WEIGHT LOSS OUTCOMES IN RESPONSE TO TREATMENT WITH DUODENAL-JEJUNAL BYPASS LINER ARE THE SAME REGARDLESS OF DIABETES SEVERITY ASSESSED USING THE INDIVIDUALIZED METABOLIC SURGERY SCOREIdris, Iskandar, Benes, Marek, Haluzik, Martin, Byrne, James, Munro, Lynne, Frydenberg, Harry, Teare, Julian, Ruban, Aruchuna, Mason, John, Holtmann, Gerald, Mcmaster, Jess and Ryder, Robert (2026). WEIGHT LOSS OUTCOMES IN RESPONSE TO TREATMENT WITH DUODENAL-JEJUNAL BYPASS LINER ARE THE SAME REGARDLESS OF DIABETES SEVERITY ASSESSED USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE. THOUSAND OAKS: SAGE PUBLICATIONS INC. |
|
2026 Journal Article Measuring lifetime alcohol exposure: A scoping review and implications for translational research and alcohol‐related harmPalmer, Andrew J., Connor, Jason P., Holtmann, Gerald, Saunders, John B., Rice, Katie, Yeo, Jeremy, Huang, Andrea and Clark, Paul J. (2026). Measuring lifetime alcohol exposure: A scoping review and implications for translational research and alcohol‐related harm. Addiction, 121 (3), 472-487. doi: 10.1111/add.70208 |
|
2026 Journal Article Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forwardGrady, John, Johnson, Kevin M., Kellermayer, Richard, Winter, Harland S., Tabibian, James H., Buness, Cynthia W., Fischer, Ryan, Shah, Ayesha, Dulai, Parambir S., Rangnekar, Amol S., Alrabadi, Leina, Shah, Shamita B., Holtmann, Gerald, Räisänen, Laura, Lewindon, Peter and Ali, Ahmad H. (2026). Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward. Expert Review of Gastroenterology & Hepatology, 20 (3) 17474124.2026.2635420, 233-246. doi: 10.1080/17474124.2026.2635420 |
|
2026 Journal Article Sociocultural Aspects of the Pathophysiology, Clinical Presentation and Management of Disorders of Gut-Brain InteractionWong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna C., Mulak, Agata, Lee, Yeong Yeh, Sperber, Ami D. and Holtmann, Gerald (2026). Sociocultural Aspects of the Pathophysiology, Clinical Presentation and Management of Disorders of Gut-Brain Interaction. Gastroenterology, 170 (6), 1190-1204. doi: 10.1053/j.gastro.2026.02.006 |
|
2026 Journal Article Disorders of gut–brain interaction (DGBI) symptoms and response to peroral endoscopic myotomy in patients with achalasiaJacob, Ronen Ben, Fairlie, Thomas, Talley, Nicholas J., Taylor, Andrew, Frankel, Adam, Smithers, B. Mark, Pandolfino, John E., Jones, Michael P., Hourigan, Luke F., Shah, Ayesha and Holtmann, Gerald (2026). Disorders of gut–brain interaction (DGBI) symptoms and response to peroral endoscopic myotomy in patients with achalasia. Neurogastroenterology and Motility, 38 (1) e70223, 1-11. doi: 10.1111/nmo.70223 |
|
2025 Journal Article Evidence for brain‐to‐gut and gut‐to‐brain pathways in primary care patients with disorders of gut‐brain interaction, inflammatory bowel disease and gastroesophageal reflux diseaseKoloski, N. A., Jones, M. P., Shah, A., Holtmann, G. and Talley, N. J. (2025). Evidence for brain‐to‐gut and gut‐to‐brain pathways in primary care patients with disorders of gut‐brain interaction, inflammatory bowel disease and gastroesophageal reflux disease. Neurogastroenterology and Motility, 37 (12) e70117, e70117. doi: 10.1111/nmo.70117 |
|
2025 Journal Article Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. a grounded theory studyMarinucci, Nicole, Koloski, Natasha, Baker, Kate, Moy, Naomi and Holtmann, Gerald (2025). Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. a grounded theory study. Australian and New Zealand Journal of Public Health, 49 (6) 100295, 100295. doi: 10.1016/j.anzjph.2025.100295 |
|
2025 Conference Publication Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic EsophagitisMalone, Amanda, Helliwell, James, Kowalski, Mark, Nguyen, Nam, Ko, Hin Hin, Holtmann, Gerald, Afif, Waqqas, Bredenoord, Albert J., Dobek, Christine, Ravikumar, Pranali, Peck, Vik and Dellon, Evan S. (2025). Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic Esophagitis. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.14309/01.ajg.0001131024.83021.f2 |
|
2025 Journal Article Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel DiseasesMoniruzzaman, Md, Shah, Ayesha, Fairlie, Thomas, Keely, Simon, Burns, Grace L., Talley, Nicholas and Holtmann, Gerald (2025). Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases. United European Gastroenterology Journal, 13 (9) ueg2.70115, 1-14. doi: 10.1002/ueg2.70115 |
|
2025 Conference Publication Updated dose escalation results from RESOLVE, an ongoing Phase 1b/2a study of EP-104GI (long-acting fluticasone propionate injectable suspension) for eosinophilic esophagitisMalone, Amanda, Helliwell, James, Kowalski, Mark M., Ko, Hin Hin, Holtmann, Gerald, Afif, Waqqas, Bredenoord, Albert J., Dellon, Evan S., Dobek, Christine, Ravikumar, Pranali, Peck, Vik and Nguyen, Nam (2025). Updated dose escalation results from RESOLVE, an ongoing Phase 1b/2a study of EP-104GI (long-acting fluticasone propionate injectable suspension) for eosinophilic esophagitis. HOBOKEN: WILEY. |
|
2025 Journal Article Randomized, placebo‐controlled, double‐blind 8‐week trial on the efficacy of a proprietary kiwifruit extract on constipation‐predominant irritable bowel syndromeHoltmann, Gerald, Talley, Nicholas J., Nandurkar, Sanjay and Gibson, Peter R. (2025). Randomized, placebo‐controlled, double‐blind 8‐week trial on the efficacy of a proprietary kiwifruit extract on constipation‐predominant irritable bowel syndrome. JGH Open, 9 (8) e70250, e70250. doi: 10.1002/jgh3.70250 |
|
2025 Journal Article Investigating participation in the Australian National Bowel Cancer Screening Program through general practice: a survey on practices, challenges and digital opportunitiesMarinucci, Nicole, Koloski, Natasha, Whaley, Amanda, Bagnall, Rachael, Shah, Ayesha, Goodwin, Belinda and Holtmann, Gerald (2025). Investigating participation in the Australian National Bowel Cancer Screening Program through general practice: a survey on practices, challenges and digital opportunities. Public Health Research and Practice, 35 (3) PU24017, 1-8. doi: 10.1071/pu24017 |
|
2025 Journal Article Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interactionMoniruzzaman, Md, Shah, Ayesha, Morrison, Mark, Koloski, Natasha, Gwee, Kok Ann, Chen, Minhu, Kim, YongSung, Ayaki, Kana, Efferth, Thomas and Holtmann, Gerald (2025). Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction. Digestive and Liver Disease, 57 (9), 1717-1729. doi: 10.1016/j.dld.2025.07.010 |
|
2025 Journal Article Navigating the maze of functional dyspepsia: emergence of a new entity, postprandial epigastric pain syndromeVan de Bruaene, Cedric, Carbone, Florencia, Van den Houte, Karen, Colomier, Esther, Raymenants, Karlien, Broeders, Bert, Balsiger, Lukas M., Jones, Mike P., Simrén, Magnus, Bai, Tao, Liu, Jinsong, Melchior, Chloé, Gourcerol, Guillaume, Chuah, Kee-Huat, Hui, Khoo Xin, Mahadeva, Sanjiv, Siah, Kewin Tien Ho, Gwee, Kok-Ann, Lipták, Peter, Banovcin, Peter, Holtmann, Gerald, Koloski, Natasha, Carabotti, Marilia, Annibale, Bruno, Suzuki, Hidekazu, Sano, Masaya, Ueda, Takashi, Shahoon, Hassan, Adibi, Peyman ... Tack, Jan (2025). Navigating the maze of functional dyspepsia: emergence of a new entity, postprandial epigastric pain syndrome. Clinical Gastroenterology and Hepatology, 23 (13), 2607-2615. doi: 10.1016/j.cgh.2025.05.017 |
|
2025 Journal Article Comparison of the prevalence of meal‐related nausea in different functional dyspepsia subgroupsBroeders, Bert, Colomier, Esther, Carbone, Florencia, Simrén, Magnus, Bai, Tao, Liu, Jinsong, Melchior, Chloé, Gourcerol, Guillaume, Chuah, Kee‐Huat, Hui, Khoo Xin, Mahadeva, Sanjiv, Siah, Kewin Tien Ho, Gwee, Kok‐Ann, Lipták, Peter, Banovcin, Peter, Holtmann, Gerald, Koloski, Natasha, Carabotti, Marilia, Annibale, Bruno, Suzuki, Hidekazu, Sano, Masaya, Ueda, Takashi, Shahoon, Hassan, Adibi, Peyman, Van de Bruaene, Cedric, Vanuytsel, Tim and Tack, Jan (2025). Comparison of the prevalence of meal‐related nausea in different functional dyspepsia subgroups. Neurogastroenterology & Motility, 38 (4) e70078, 1-8. doi: 10.1111/nmo.70078 |
|
2025 Conference Publication The impact of a formalized frailty assessment on patient satisfaction and demand for surveillance colonoscopy in patients over 65 yearsKoloski, Natasha, Virgo, Kate, Moy, Naomi, Whaley, Amanda, Shah, Ayesha, Hansen, Teressa J., Pickering, John, La Rue, Crystal, Hubbard, Ruth, Reid, Natasha, Jones, Michael P. and Holtmann, Gerald J. (2025). The impact of a formalized frailty assessment on patient satisfaction and demand for surveillance colonoscopy in patients over 65 years. Digestive Disease Week (DDW) 2025, San Diego, CA United States, 3-6 August 2025. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(25)03296-2 |
